Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
I. López-Rodríguez, A. Castro-Beiras, A. Asensi, F. Bacariza, J.M. Rábade, J. Muñiz.
Normas básicas de manejo de la insuficiencia cardíaca en atención primaria.
Aten Primaria, 24 (1999), pp. 289-294
[2.]
B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Pérez, et al.
for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure.
N Engl J Med, 341 (1999), pp. 709-717
[3.]
A.M. Chonko, J.J. Grantham.
Diuretics.
Cardiovascular pharmacology, pp. 2.1-2.21
[4.]
J.A. Rodríguez, I. Godoy, P. Castro, J.C. Quintana, E. Chávez, J. Yovanovich, et al.
Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study.
Rev Med Chil, 125 (1997), pp. 643-652
[5.]
A. Sato, Y. Suzuki, T. Saruta.
Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
Hypertens Res, 22 (1999), pp. 17-22
[6.]
S. Degre, J.M. Detry, P. Unger, J. Cosyns, C. Brohet, N. Kormoss.
Effects of spironolactone-altizide on left ventricular hypertrophy.
Acta Cardiol, 53 (1998), pp. 261-267
[7.]
T. Kinugawa, K. Ogino, M. Kato, Y. Furuse, M. Shimoyama, M. Mori, et al.
Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor.
Gen Pharmacol, 31 (1998), pp. 93-99
[8.]
R.J. MacFadyen, C.S. Barr, A.D. Struthers.
Aldosterone blockade reduces vascullar collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients.
Cardiovasc Res, 35 (1997), pp. 30-34
[9.]
N. Klauber, F. Browne, B. Anand-Apte, R.J. D'Amato.
New activity of spironolactone. Inhibition of angiogenesis in vitro and in vivo.
Circulation, 94 (1996), pp. 2566-2571
[10.]
K.T. Weber.
Aldosterone and spironolactone in heart failure.
N Engl J Med, 341 (1999), pp. 753-755
Copyright © 2000. Elsevier España, S.L.. Todos los derechos reservados
